vs
Side-by-side financial comparison of PERRIGO Co plc (PRGO) and PRICESMART INC (PSMT). Click either name above to swap in a different company.
PRICESMART INC is the larger business by last-quarter revenue ($1.4B vs $1.1B, roughly 1.2× PERRIGO Co plc). PRICESMART INC runs the higher net margin — 2.9% vs -127.8%, a 130.7% gap on every dollar of revenue. On growth, PRICESMART INC posted the faster year-over-year revenue change (9.9% vs -2.5%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $32.6M). Over the past eight quarters, PRICESMART INC's revenue compounded faster (3.5% CAGR vs 1.3%).
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
PRICESMART INCPSMTEarnings & Financial Report
PriceSmart, Inc. is a United States based operator of membership warehouse clubs in Central America, the Caribbean, and South America. PriceSmart was founded by Sol and Robert Price, founders of Price Club; Robert Price is chairman of the board.
PRGO vs PSMT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $1.4B |
| Net Profit | $-1.4B | $40.2M |
| Gross Margin | 32.6% | 17.7% |
| Operating Margin | -116.0% | 4.6% |
| Net Margin | -127.8% | 2.9% |
| Revenue YoY | -2.5% | 9.9% |
| Net Profit YoY | -3093.9% | 7.3% |
| EPS (diluted) | $-10.23 | $1.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $1.4B | ||
| Q3 25 | $1.0B | $1.3B | ||
| Q2 25 | $1.1B | $1.3B | ||
| Q1 25 | $1.0B | $1.4B | ||
| Q4 24 | $1.1B | $1.3B | ||
| Q3 24 | $1.1B | $1.2B | ||
| Q2 24 | $1.1B | $1.2B | ||
| Q1 24 | $1.1B | $1.3B |
| Q4 25 | $-1.4B | $40.2M | ||
| Q3 25 | $7.5M | $31.5M | ||
| Q2 25 | $-8.4M | $35.2M | ||
| Q1 25 | $-6.4M | $43.8M | ||
| Q4 24 | $-44.4M | $37.4M | ||
| Q3 24 | $-21.0M | $29.1M | ||
| Q2 24 | $-108.4M | $32.5M | ||
| Q1 24 | $2.0M | $39.3M |
| Q4 25 | 32.6% | 17.7% | ||
| Q3 25 | 36.1% | — | ||
| Q2 25 | 34.4% | — | ||
| Q1 25 | 37.6% | 17.1% | ||
| Q4 24 | 33.9% | 17.4% | ||
| Q3 24 | 37.2% | — | ||
| Q2 24 | 37.0% | — | ||
| Q1 24 | 33.1% | — |
| Q4 25 | -116.0% | 4.6% | ||
| Q3 25 | 7.0% | 4.0% | ||
| Q2 25 | 4.3% | 4.3% | ||
| Q1 25 | 4.5% | 4.8% | ||
| Q4 24 | 10.0% | 4.6% | ||
| Q3 24 | 7.4% | 4.0% | ||
| Q2 24 | -2.5% | 4.1% | ||
| Q1 24 | -5.1% | 4.9% |
| Q4 25 | -127.8% | 2.9% | ||
| Q3 25 | 0.7% | 2.4% | ||
| Q2 25 | -0.8% | 2.7% | ||
| Q1 25 | -0.6% | 3.2% | ||
| Q4 24 | -3.9% | 3.0% | ||
| Q3 24 | -1.9% | 2.4% | ||
| Q2 24 | -10.2% | 2.6% | ||
| Q1 24 | 0.2% | 3.0% |
| Q4 25 | $-10.23 | $1.29 | ||
| Q3 25 | $0.05 | $1.02 | ||
| Q2 25 | $-0.06 | $1.14 | ||
| Q1 25 | $-0.05 | $1.45 | ||
| Q4 24 | $-0.32 | $1.21 | ||
| Q3 24 | $-0.15 | $0.94 | ||
| Q2 24 | $-0.79 | $1.08 | ||
| Q1 24 | $0.01 | $1.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $320.6M |
| Total DebtLower is stronger | — | $180.3M |
| Stockholders' EquityBook value | $2.9B | $1.3B |
| Total Assets | $8.5B | $2.4B |
| Debt / EquityLower = less leverage | — | 0.14× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $320.6M | ||
| Q3 25 | $432.1M | $314.2M | ||
| Q2 25 | $454.2M | $262.4M | ||
| Q1 25 | $409.9M | $247.3M | ||
| Q4 24 | $558.8M | $222.2M | ||
| Q3 24 | $1.5B | $225.5M | ||
| Q2 24 | $542.8M | $228.2M | ||
| Q1 24 | $658.5M | $264.2M |
| Q4 25 | — | $180.3M | ||
| Q3 25 | — | $186.6M | ||
| Q2 25 | — | $103.1M | ||
| Q1 25 | — | $107.1M | ||
| Q4 24 | — | $115.6M | ||
| Q3 24 | — | $130.4M | ||
| Q2 24 | — | $135.1M | ||
| Q1 24 | — | $140.0M |
| Q4 25 | $2.9B | $1.3B | ||
| Q3 25 | $4.4B | $1.2B | ||
| Q2 25 | $4.5B | $1.2B | ||
| Q1 25 | $4.4B | $1.2B | ||
| Q4 24 | $4.3B | $1.2B | ||
| Q3 24 | $4.6B | $1.1B | ||
| Q2 24 | $4.5B | $1.1B | ||
| Q1 24 | $4.7B | $1.1B |
| Q4 25 | $8.5B | $2.4B | ||
| Q3 25 | $10.1B | $2.3B | ||
| Q2 25 | $10.1B | $2.1B | ||
| Q1 25 | $9.8B | $2.1B | ||
| Q4 24 | $9.6B | $2.1B | ||
| Q3 24 | $11.2B | $2.0B | ||
| Q2 24 | $10.4B | $2.0B | ||
| Q1 24 | $10.6B | $2.0B |
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | 0.10× | ||
| Q3 24 | — | 0.12× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.13× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $175.4M | $71.2M |
| Free Cash FlowOCF − Capex | $148.6M | $32.6M |
| FCF MarginFCF / Revenue | 13.4% | 2.4% |
| Capex IntensityCapex / Revenue | 2.4% | 2.8% |
| Cash ConversionOCF / Net Profit | — | 1.77× |
| TTM Free Cash FlowTrailing 4 quarters | $145.1M | $125.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $175.4M | $71.2M | ||
| Q3 25 | $51.7M | $82.1M | ||
| Q2 25 | $75.9M | $52.8M | ||
| Q1 25 | $-64.5M | $87.9M | ||
| Q4 24 | $312.6M | $38.5M | ||
| Q3 24 | $42.2M | $41.8M | ||
| Q2 24 | $9.5M | $38.1M | ||
| Q1 24 | $-1.4M | $86.6M |
| Q4 25 | $148.6M | $32.6M | ||
| Q3 25 | $29.8M | $25.6M | ||
| Q2 25 | $56.7M | $14.0M | ||
| Q1 25 | $-90.0M | $53.2M | ||
| Q4 24 | $274.9M | $10.3M | ||
| Q3 24 | $15.1M | $15.2M | ||
| Q2 24 | $-18.9M | $-308.0K | ||
| Q1 24 | $-26.5M | $16.4M |
| Q4 25 | 13.4% | 2.4% | ||
| Q3 25 | 2.9% | 1.9% | ||
| Q2 25 | 5.4% | 1.1% | ||
| Q1 25 | -8.6% | 3.9% | ||
| Q4 24 | 24.2% | 0.8% | ||
| Q3 24 | 1.4% | 1.2% | ||
| Q2 24 | -1.8% | -0.0% | ||
| Q1 24 | -2.4% | 1.3% |
| Q4 25 | 2.4% | 2.8% | ||
| Q3 25 | 2.1% | 4.2% | ||
| Q2 25 | 1.8% | 2.9% | ||
| Q1 25 | 2.4% | 2.5% | ||
| Q4 24 | 3.3% | 2.2% | ||
| Q3 24 | 2.5% | 2.2% | ||
| Q2 24 | 2.7% | 3.1% | ||
| Q1 24 | 2.3% | 5.4% |
| Q4 25 | — | 1.77× | ||
| Q3 25 | 6.89× | 2.60× | ||
| Q2 25 | — | 1.50× | ||
| Q1 25 | — | 2.01× | ||
| Q4 24 | — | 1.03× | ||
| Q3 24 | — | 1.44× | ||
| Q2 24 | — | 1.17× | ||
| Q1 24 | -0.70× | 2.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
PSMT
| Fresh Foods | $454.9M | 33% |
| Caribbean Operations Segment | $396.5M | 29% |
| Colombia Operations Segment | $204.1M | 15% |
| Hardlines | $162.6M | 12% |
| Softlines | $99.8M | 7% |
| ship Income Member | $24.5M | 2% |
| Health Services | $14.5M | 1% |
| Other Revenue And Income | $4.2M | 0% |
| United States Operations Segment | $510.0K | 0% |
| Export Sales | $359.0K | 0% |
